The document summarizes initiatives to combat counterfeit medicines in various countries. It finds that healthcare professionals' roles are often unclear and they are not always at the forefront of counterfeiting issues. The WHPA campaign aims to strengthen advocacy for investing in healthcare professionals' education and capacity to detect, report, and prevent counterfeits. It establishes dialogue between stakeholders to share knowledge and resources and initiate cost-effective solutions. The WHPA Call to Action and toolkit provide strategies and resources to build comprehensive regional plans against counterfeiting through increasing professional capacity, regional cooperation, collaborative practice, and improved collaboration with authorities.

1. Xuanhao CHAN
International Pharmaceutical
Federation (FIP) and WHPA

2. Background: The 2011 WHPA rapid
review of 24 national initiatives
review of 24 national initiatives
combating counterfeit medicines
3 No collaboration between HCP associations and other stakeholders.
No activities concerning counterfeit medicines documented
Limited collaboration among HCP and stakeholders. Groups may
15 organise one‐off activities such as public campaigns
Existence of a national stakeholder group with defined structures
6 and scope of work combating counterfeit medicines
Nigeria, Indonesia, US, China Taiwan, Costa Rica and UK

3. Key observations from the WHPA rapid review
of 24 national initiatives combating counterfeit
of 24 national initiatives combating counterfeit
medicines
• The actual roles played by health professionals in
The actual roles played by health professionals in
these countries seem to be very much unclear in the
majority of the countries.
• Most of the documented initiatives against
medicines counterfeiting are mainly by government
bodies and their agencies.
• Healthcare professionals are often not educated and
informed about their roles in national initiatives.
f d b h l l
• Health professionals are not always at the forefront
of the battle against medicines counterfeiting.
f th b ttl i t di i t f iti

4. WHPA campaign s mandate
WHPA campaign’s mandate
• To strengthen advocacy for appropriate investments
To strengthen advocacy for appropriate investments
in the education and capacity of health professionals
to detect, report and prevent infiltration of
counterfeit medical products in the supply chain.
• By establishing dialogue with government bodies and
agencies, inter‐professional and inter‐disciplinary
networks can create an opportunity for knowledge
and resources to be shared and for cost‐effective
and resources to be shared and for cost effective
solutions to be initiated.

5. San José, 22nd October 2010
San José, 22 October 2010

6. Abuja, 22nd November 2010
Abuja, 22 November 2010

7. Taipei, 30th June 2011
Taipei, 30 June 2011

8. Main elements of the WHPA Call to Action
adapted in Africa, Central America and Asia
d di f i l i d i
• 4 key strategies for the basis of a
4 key strategies for the basis of a
comprehensive regional action plan against
counterfeiting of medical products:
counterfeiting of medical products:
– Increase capacity of healthcare professionals
– Foster regional cooperation initiatives
Foster regional cooperation initiatives
– Strengthen collaborative practice
– Impro e collaboration ith health and
Improve collaboration with health and
enforcement authorities plus other key
stakeholders

9. WHPA toolkit and other campaign
resources www.whpa.org/counterfeit_campaign.htm
• Campaign folder, FAQs
p g , Q
and introduction
• 5 fact sheets for health
professionals, advocates
f l d
and patients
• Counterfeit medical
Counterfeit medical
product sample
reporting form
• 2 posters and 3
postcards
• WHPA Joint Statement